Atlas Trials

Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Clinical trial NCT05254821 · UNKNOWN

Trial details

NCT number
NCT05254821
Sponsor
Federico II University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hodgkin Lymphoma
Start date
2022-01-10
Primary completion
2024-02-03
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.